在年轻人中对甲基胺使用和中风的审查
Kafi Hemphill1, Shannon Tierney1, David Tirschwell1
1Harborview Medical Center, University of Washington, Seattle, WA, United States.
Frontiers in neurology
|May 9, 2024
概括
甲基胺使用与年轻人的中风风险增加有关,特别是出血性中风. 戒除甲基胺是主要的治疗方法,因为没有特定于甲基胺的干预措施.
科学领域:
- 神经学 神经学
- 毒理学 毒理学 毒理学
- 公共卫生 公共卫生
背景情况:
- 甲基胺 (meth) 是一种强大的中枢神经系统兴奋剂,使用量不断增加.
- 脑卒中是一种与甲基胺使用相关的显著神经血管并发症.
- 与甲基胺相关的中风不成比例地影响年轻人群,这可能解释了这一人口群体中中风发病率上升的原因.
研究的目的:
- 审查有关甲基胺相关神经血管并发症的文献.
- 介绍两项年轻患者在使用甲基胺后发生中风的案例研究.
- 讨论有关甲基胺相关中风的拟议病理生理机制和治疗考虑.
主要方法:
- 关于甲基胺相关中风的案例研究和系列的文献综述.
- 两名年轻患者 (年龄在50岁以下) 的临床病例介绍,他们最近使用了甲基和中风 (一个内出血,一个缺血性中风).
主要成果:
- 在甲基胺使用者中,出血性中风 (脑内和脑下) 似乎比缺血性中风更常见.
- 出血性中风的拟议机制包括高血压激增,血管和动脉瘤破裂.
- 缺血性中风的机制可能涉及加速动脉样硬化,心脏问题和血管炎.
结论:
- 与甲基胺相关的中风是一个严重的问题,特别是在年轻患者中.
- 建议采用标准的中风治疗,并强制戒除甲基胺.
- 需要进行更大规模的前性研究,以更好地理解和管理这些毁灭性的结果.
更多相关视频
09:16A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration
Published on: January 22, 2016
15.2K
08:53Assessing Neuroprotective Effects of Glycyrrhizae Radix et Rhizoma Extract Using a Transient Middle Cerebral Artery Occlusion Mouse Model
Published on: December 9, 2018
7.4K
相关概念视频
Drug Regulation
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
Drug Dependence
Medications are typically administered to achieve therapeutic effects. Some drugs can modify an individual's mood and perception, frequently resulting in various enjoyable experiences. However, this can result in drug dependency, a condition marked by continuous drug use despite potential negative consequences. Drug dependency primarily falls into two categories: psychological and physical dependence. Psychological dependence occurs when the pleasurable feelings induced by the drug...
Effects of Chemicals: Overview
Drugs, encompassing various chemical compounds from natural sources, lab synthesis, or genetic engineering, elicit different biological responses in living organisms. Some of these responses are desirable or therapeutic, while others are undesirable. The primary goal of administering a drug is to achieve a therapeutic effect, that is, to address a specific disease or health condition. Any concurrent effects outside of this therapeutic outcome are considered undesirable. These undesirable...
Mutagenicity and Carcinogenicity
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
Pharmacokinetics in Pediatric Patients: Drug Metabolism
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
